Skip to main content
Caplight Logo









NeoGenix Biosciences

NeoGenix Biosciences

Private
SydneyHealthcare & Life Scienceshttps://www.neogenixbiosciences.com/

Last Round

Pre Seed

Mar 11, 2024

Total Funding Raised

$145,000

Company Overview

NeoGenix Biosciences is a biotechnology company that develops AI-powered and microfluidic platforms to enhance sperm identification and selection for IVF procedures.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS

AI Layer

Application

Keywords

IVF technologymicrofluidicssperm selectionfertility techmedical AIassisted reproductive technologyARTmale infertilityembryology toolsAI image analysisbiomimetic devicesnon-obstructive azoospermiaNOAfertility clinic softwaremedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NeoGenix Biosciences Comparables

Compare NeoGenix Biosciences with similar companies based on industry and business-model similarity.

NeoGenix Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
iPreg Inc.
86%
Koek Biotechnology Ltd.
77%
Memphasys Ltd
75%

NeoGenix Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedMar 11, 2024
AcceleratorOct 26, 2023

Key People

Founding team and executive leadership

Steven Vasilescu

Co-Founder and CEO

Founding Team

Saeed Fathi

Technical Advisor & Fractional CTO

Executive Team

NeoGenix Biosciences Investors

Notable investors and investment history

NeoGenix Biosciences investors
InvestorRounds
Australian Medical AngelsAccelerator
The George Institute for Global HealthAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 11, 2024

    $65K round led by Virtus Health

  • Oct 26, 2023

    $80K raised from Australian Medical Angels and others.

NeoGenix Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

NeoGenix Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NeoGenix Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersSydney
Employee Range6
Year Founded2022
Last FundingMar 11, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?